MedPath

A Pilot Study of Intensive Supplemental Insulin Therapy: Novorapid vs Actrapid

Not Applicable
Recruiting
Conditions
Diabetes mellitus
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12608000402347
Lead Sponsor
W Cheung
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

diabetes
on oral agents or insulin

Exclusion Criteria

pregnant
ketoacidosis
nil by mouth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath